Literature DB >> 2773515

Herpes simplex latent infection: quantitation of latency-associated transcript-positive neurons and reactivable neurons.

R B Tenser1, W A Edris, K A Hay.   

Abstract

Dorsal root ganglion neurons, which express herpes simplex virus (HSV) latency-associated transcript (LAT) during experimental latent infection, were investigated by in situ hybridization. The number of LAT-positive neurons was determined by examination of ganglion serial sections. In other latently infected mice, the number of ganglion neurons that reactivated HSV antigen after explant culture was determined in serial sections. LAT was detected in 100 percent of ganglia, with an average of 19.5 LAT-positive neurons per ganglion. After explant culture of latently infected ganglia (in the presence of colchicine to decrease spread of reactivated virus), HSV antigen was detected in 94 percent of ganglia, with an average of 13.1 positive neurons in the antigen-positive ganglia. The similar quantities of LAT- and antigen-positive neurons within ganglia support the hypothesis that LAT-positive neurons were the neurons from which HSV was reactivated.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2773515      PMCID: PMC2589233     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  22 in total

1.  Latent herpes simplex virus type 1 transcripts in peripheral and central nervous system tissues of mice map to similar regions of the viral genome.

Authors:  A M Deatly; J G Spivack; E Lavi; D R O'Boyle; N W Fraser
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

2.  Detection of latency-related viral RNAs in trigeminal ganglia of rabbits latently infected with herpes simplex virus type 1.

Authors:  D L Rock; A B Nesburn; H Ghiasi; J Ong; T L Lewis; J R Lokensgard; S L Wechsler
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

3.  RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons.

Authors:  J G Stevens; E K Wagner; G B Devi-Rao; M L Cook; L T Feldman
Journal:  Science       Date:  1987-02-27       Impact factor: 47.728

4.  The number of neurons in dorsal root ganglia L4-L6 of the rat.

Authors:  H Schmalbruch
Journal:  Anat Rec       Date:  1987-11

5.  Physical characterization of the herpes simplex virus latency-associated transcript in neurons.

Authors:  E K Wagner; G Devi-Rao; L T Feldman; A T Dobson; Y F Zhang; W M Flanagan; J G Stevens
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

6.  Herpes simplex and herpes zoster. Nervous system involvement.

Authors:  R B Tenser
Journal:  Neurol Clin       Date:  1984-05       Impact factor: 3.806

7.  RNA complementary to herpes simplex virus type 1 ICP0 gene demonstrated in neurons of human trigeminal ganglia.

Authors:  Y J Gordon; B Johnson; E Romanowski; T Araullo-Cruz
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

8.  Expression of herpes simplex virus type 1 latency-associated transcripts in the trigeminal ganglia of mice during acute infection and reactivation of latent infection.

Authors:  J G Spivack; N W Fraser
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

9.  Detection of HSV-1 genome in central nervous system of latently infected mice.

Authors:  D L Rock; N W Fraser
Journal:  Nature       Date:  1983-04-07       Impact factor: 49.962

10.  Hybridization between a repeated region of herpes simplex virus type 1 DNA containing the sequence [GGC]n and heterodisperse cellular DNA and RNA.

Authors:  D J Spector; T R Jones; C L Parks; A M Deckhut; R W Hyman
Journal:  Virus Res       Date:  1987-02       Impact factor: 3.303

View more
  2 in total

1.  Comprehensive quantification of herpes simplex virus latency at the single-cell level.

Authors:  N M Sawtell
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

2.  The herpes simplex virus type 1 latency-associated transcript gene regulates the establishment of latency.

Authors:  R L Thompson; N M Sawtell
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.